Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Maiwei Medical Technology is a specialized medical device company focused on the development of innovative interventional solutions for complex vascular diseases. The company's core expertise lies in Intravascular Lithotripsy (IVL) technology, which utilizes sonic pressure waves to selectively disrupt calcium deposits within arterial walls while minimizing trauma to soft tissue. Their flagship M-Power system is designed to treat severely calcified coronary and peripheral artery lesions, facilitating more effective balloon angioplasty and stent placement. Based in Shenzhen's high-tech hub, the company integrates R&D, manufacturing, and clinical application to address unmet needs in the cardiovascular interventional market. Maiwei Medical is recognized as a leader in the domestic Chinese IVL space, having received innovative device designations for its proprietary technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Maiwei Medical Technology.